ダウンロード数: 256

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
30_537.pdf453.06 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.author安川, 明廣ja
dc.contributor.author仁平, 寛巳ja
dc.contributor.author松木, 暁ja
dc.contributor.author藤井, 元広ja
dc.contributor.author藤原, 英祐ja
dc.contributor.author北野, 太路ja
dc.contributor.author児玉, 光人ja
dc.contributor.author鵜飼, 麟三ja
dc.contributor.author田戸, 治ja
dc.contributor.author相模, 浩二ja
dc.contributor.author姫野, 安敏ja
dc.contributor.alternativeYASUKAWA, Akihiroen
dc.contributor.alternativeNIHIRA, Hiromien
dc.contributor.alternativeMATSUKI, Satoruen
dc.contributor.alternativeFUJII, Motohiroen
dc.contributor.alternativeFUJIWARA, Hidesukeen
dc.contributor.alternativeKITANO, Taijien
dc.contributor.alternativeKODAMA, Mitsutoen
dc.contributor.alternativeUKAI, Rinzoen
dc.contributor.alternativeTADO, Osamuen
dc.contributor.alternativeSAGAMI, Kohjien
dc.contributor.alternativeHIMENO, Yasutoshien
dc.date.accessioned2010-06-02T01:36:07Z-
dc.date.available2010-06-02T01:36:07Z-
dc.date.issued1984-04-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/118152-
dc.description.abstractForty-three patients with benign prostatic hyperplasia were treated with weekly i.m. injections of 400 mg oxendolone for 12 weeks. The subjective symptoms were improved in 83% of these patients. Residual urine was decreased significantly and Qmax was increased by this treatment. Serum VLDL level was suppressed significantly, whereas the levels of LDL, total cholesterol, HDL-cholesterol and triglycerides were changed little. Atherosclerotic index and the ratio of (total cholesterol--HDL-cholesterol) to (HDL-cholesterol), was not influenced by the treatment. No severe side-effect was found. These findings suggest that oxendolone is the drug of choice for non-surgical treatment of benign prostatic hyperplasia.en
dc.format.mimetypeapplication/pdf-
dc.language.isojpn-
dc.publisher泌尿器科紀要刊行会ja
dc.subjectOxendoloneen
dc.subjectUroflowmetryen
dc.subjectSerum lipidsen
dc.subjectLipoproteinen
dc.subject.ndc494.9-
dc.title前立腺肥大症に対するオキセンドロンの使用経験 --臨床効果と血清脂質への影響について--ja
dc.title.alternativeClinical experience with oxendolone for treatment of benign prostatic hyperplasia. Clinical efficacy and effects on serum lipid and lipoprotein fraction levelsen
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume30-
dc.identifier.issue4-
dc.identifier.spage537-
dc.identifier.epage543-
dc.textversionpublisher-
dc.sortkey14-
dc.address広島大学医学部泌嚴器科学教室ja
dc.address広島大学医学部泌嚴器科学教室ja
dc.address国立福山病院泌尿器科ja
dc.address広島総合病院泌尿器科ja
dc.address広島総合病院泌尿器科ja
dc.address双三中央病院泌尿器科ja
dc.address尾道総合病院泌尿器科ja
dc.address中国労災病院泌尿器科ja
dc.address広島市立安佐市民病院泌膿器科ja
dc.address島根県立中央病院泌尿器科ja
dc.address島根県立中央病院泌尿器科ja
dc.address.alternativethe Department of Urology, Hiroshima University School of Medicineen
dc.address.alternativethe Department of Urology, Hiroshima University School of Medicineen
dc.address.alternativethe Department of Urology, Fukuyama National Hospitalen
dc.address.alternativethe Department of Urology, Koseiren Hiroshima General Hospitalen
dc.address.alternativethe Department of Urology, Koseiren Hiroshima General Hospitalen
dc.address.alternativethe Department of Urology, Futami Central Hospitalen
dc.address.alternativethe Department of Urology, Onomichi General Hospitalen
dc.address.alternativethe Department of Urology, Chugoku Rosai Hospitalen
dc.address.alternativethe Department of Urology, Hiroshima Municipal Asa Citizens Hospitalen
dc.address.alternativethe Department of Urology, Shimane Prefectural Central Hospitalen
dc.address.alternativethe Department of Urology, Shimane Prefectural Central Hospitalen
dc.identifier.pmid6207714-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.30 No.4

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。